Thomas Langenickel

Thomas Langenickel

Company: Ethris

Job title: CMO

Seminars:

Targeting Immunomodulation with mRNA- Based Therapeutics 11:45 am

Read more

day: Day One

Targeting Immunomodulation with mRNA- Based Therapeutics 11:45 am

How Ethris is employing its modified mRNA, formulation and inhaled delivery technology platforms towards development of mRNA therapeutics for treatment of lung diseases Utilizing inhaled mRNA therapeutics to modulate immune responses in the lung provides novel opportunities to treat autoimmune diseases and respiratory viral infections beyond vaccinesRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.